热门资讯> 正文

萨瓦拉公司在收购猜测中，

2025-12-03 03:39

Mast Therapeutics(SVRA) 0

Savara Inc. (SVRA) pared a loss and ticked higher by 0.2% amid takeover speculation.
There's speculation that Savara may have attracted takeover interest, according to traders, who cited a Betaville "uncooked" alert that was circulating on Tuesday. The identity of the potential buyer wasn't known.
Shares of Savara (SVRA) have risen more than 80% this year. The biotech has a market cap of $1.4 billion.

More on Savara

Savara: A High-Risk Opportunity
Savara: Back On Track With Upcoming APAP BLA Filing
Savara prices $130M equity at $4.20
Savara announces proposed public offering
Seeking Alpha’s Quant Rating on Savara

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。